Primary prevention of colorectal cancer

Acta Gastro-Enterologica Belgica

Volumn 66, Issue 1, 2003, Pages 20-27

  Buset, M ^a  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ESTROGEN; NONSTEROID ANTIINFLAMMATORY AGENT; VITAMIN;

ADENOCARCINOMA; COLORECTAL CANCER; DIETARY FIBER; ENERGY BALANCE; ENVIRONMENTAL FACTOR; EXERCISE; FAT INTAKE; HEREDITY; HUMAN; PRIMARY PREVENTION; REVIEW; SECONDARY PREVENTION;

ADENOCARCINOMA; COLORECTAL NEOPLASMS; DISEASE SUSCEPTIBILITY; EUROPE; HUMANS; PRIMARY PREVENTION; RISK FACTORS; UNITED STATES;

EID: 0037223618     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. ŒUVRE BELGE DU CANCER. Régitre National du Cancer, 1995.
2. WILLIAMS A.R., BALASOORIYA B.A., DAY D.W. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut, 1982, 23: 835-842.
3. WINAWER S.J. Management of gastro-intestinal diseases. Gower Medical Publishing, 1992.
4. HAENSZEL W. et al. Large bowel cancer in Hawaiian Japanese. J. Natl. Cancer Inst., 1973, 51: 1765-1779.
5. JACOBY R.F., MARSHALL D.J., NEWTON M.A. et al. Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res., 1996, 56: 710-714.
6. LIPKIN M. Strategies for intervention with chemopreventive agents. Int. J. Cancer, 1996, 69: 64-67.
7. TAKAYAMA T., KATSUKI S., TAKAHASHI Y. et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N. Engl. J. Med., 1998, 339: 1277-1284.
8. BURKITT D.P. Epidemiology of cancer of the colon and rectum. Cancer, 1971, 28: 3-13.
9. WILLETT W.C., STAMPFERM J., COLDITZ G.A. et al. Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N. Engl. J. Med., 1990, 323: 1664-1772.
10. GIOVANNUCCI E., STAMPFER M.J., COLDITZ G., RIMM E.B., WILLETT W.C. Relationship of diet to the risk of colorectal adenoma in men. J. Natl. Cancer Inst., 1992, 84: 74-75.
11. TROCH B., LANZA E., GREENWALD P. Dietary fiber, vegetables, and colon cancer: critical review and meta-analyses of the epidemiological evidence. J. Natl. Cancer Inst., 1990, 82: 650-655.
12. GREENWALD P. Colon cancer overview. Cancer, 1992, 70: 1206-1215
13. REDDY B.S. Dietary fiber and colon cancer: animal model studies. Prev. Med., 1987, 16: 559-565.
14. ALBERTS D.S., EINSPAHR J., REES-MC GEE S. et al. Effect of dietary wheat bran fiber on rectal epithelial cell proliferation in patients with resection for colorectal cancer. J. Natl. Cancer Inst., 1990, 82: 11280-5.
15. ALBERTS D.S., MARTINEZ M.E., ROE D.J. et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. N. Engl. J. Med., 2000, 342: 1156-1162.
16. SCHATZKIN A., LANZA E., CORLE D. et al. Lack of effect of a low-fat, high fiber diet on the recurrence of colorectal adenomas. N. Engl. J. Med., 2000, 342: 1149-1155
17. BONITHON-KOPP C., KRONBORG O., GIACOSA A., RATH U., FAIVRE J. Calcium and fiber supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet, 2000, 356: 1300-1306.
18. FUCHS C.S., GIOVANNUCCI E.L., COLDITZ G.A. et al. Dietary fiber and the risk of colorectal cancer and adenoma in women. N. Engl. J. Med., 1999, 340: 169-176.
19. JANNE PA, MAYER RJ. Chemoprevention of colorectal cancer. N. Engl. J. Med., 2000, 342: 1960.
20. MC KEOWN-EYSSEN G.E., BRIGHT-SEE E. Dietary factors in colon cancer international relationships. Nutr. Cancer, 1984, 6: 160-170.
21. CUMMINGS J.H., BINGHAM S.A., HEATON K.W., EASTWOOD M.A. Fecal weight, colon cancer risk, and dietary intake of nonstarch polysaccharides (dietary fiber). Gastroenterology, 1992, 103: 1783-1789.
22. HILL M.J., DRASAR B.S., ARIES V.C. et al. Bacteria and the aetiology of cancer of the large bowel. Lancet, 1971, 1: 95-100.
23. REDDY B.S., NARISAWA T., VUKUSICH D., WEISBURGER J.H., WYNDER E.L. Effect of quality and quantity of dietary fat and dimethylhydrazine in colon carcinogenesis in rats. Proc. Soc. Exp. Biol. Med., 1976, 151: 237-39.
24. REDDY B.S., BURIL C., RIGOTFY J. Effect of diets high in omega-3 and omega-6 fatty acids on initiation and postinitiation stages of colon carcinogenesis. Cancer Res., 1991, 51: 487-491.
25. REDDY B.S. Diet and excretion of bile acids. Cancer Res., 1981, 41: 3766-8.
26. REDDY B.S., HANSON D., MANGAT B. et al. Effect of high-fat, high-beef diet and mode of cooking of beef in the diet on faecal bacterial enzymes and fecal bile acids and neutral sterols. J. Nutr., 1980, 110: 1880-7.
27. GARLAND C., GARLAND F.C. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int. J. Epidemiol., 1979, 27: 155.
28. SORENSON A.W., SLATTERY M.L., FORD M.H. Calcium and colon cancer: a review. Nutr. Cancer, 1988, 11: 135-45.
29. LIPKIN M., NEWMARK H.L. Effect of added dietary calcium on colonic epithelial cell proliferation in subjects at high risk for familial colon cancer. N. Engl. J. Med., 1985, 313: 1381-4.
30. BUSET M., LIPKIN M., WINAWER S., SWAROOP S., FRIEDMAN E. Inhibition of human colonic epithelial cell proliferation in vivo and in vitro by calcium. Cancer Res., 1986, 46: 5426-5430.
31. WARGOVICH M.J., ENG V.W.S., NEWMARK H.L., BRUCE W.R. Calcium Ameliorates the toxic effect of deoxycholic acid on colonic epithelium. Carcinogenesis, 1984, 4: 1205-1207.
32. WARGOVITCH M.J., LYNCH P.M., LEVIN B. Modulating Effects of calcium in animal models of colon carcinogenesis and short-term studies in subjects at increased risk for colon cancer. Am. J. Clin. Nutr., 1991, 54: 202S-205S.
33. BARON J.A., BEACH M., MANDEL J.S. et al. Calcium supplements for the prevention of colorectal adenomas. N. Engl. J. Med., 1999, 340: 101-107.
34. BUSET M., GALAND P., LIPKIN M., WINAWER S., FRIEDMAN E. Injury induced by fatty acids or bile acid in isolated human colonocytes prevented by calcium. Cancer Letters, 1990, 50: 221-226.
35. GARFINKEL L., STELLMAN S.D. Mortality by relative weight and exercise. Cancer, 1988, 62: 1844-1850.
36. COHEN L.A., CHOI K., WANG C.X. Influence of dietary fat, caloric restriction, and voluntary exercise on N-nitroso-methylurea-induced mammary tumorigenesis in rats. Cancer Res., 1988, 48: 4276-7283.
37. SLATTERY M.L., POTTER J., CAAN B. et al. Energy balance and colon cancer - beyond physical activity. Cancer Res., 1997, 57: 75-80.
38. MC KEOWN-EYSSEN G.E. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol., Biomarkers & Prev., 1994, 3: 687-695.
39. WYSOWSKI D.K., GOLDEN L., BURKE L. Use of menopausal estrogens and medroxyprogesterone in the United States. 1982-1992. Obstet. Gynecol., 1995, 85: 291-295.
40. GREENBERG E.R., BARON J.A., TOSTESON T.D. et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. N. Engl. J. Med., 1994, 331: 141-147.
41. WADELL W.E., GANSAR G.F., CERISE E.J., LOUGHTRY R.W. Sulindac for polyposis of the colon. Am. J. Surg., 1989, 157: 175-179.
42. LABAYLE D., FISCHER D., VIELH H.P. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology, 1991, 101: 635-639.
43. WINDE G., SCHMID K.W., SCHLEGAL W., FISCHER R., OSSWALD H., BUNTE H. The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatosis polyposis: clinical results of a dosefinding study on rectal sulindac administration. Int. J. Colorect. Dis., 1993, 8: 13-17.
44. THUN M.J., NAMBOODIRI MEATH EATH C.W. Aspirin use and reduced risk of fatal colon cancer. New. Engl. J. Med., 1991, 325: 1593-1596.
45. GIOVANNUCCI E., EGAN K.M., HUNTER D.J. et al. Aspirin and the risk of colorectal cancer in women. N. Engl. J. Med., 1995, 333: 609-614
46. RAO C.V., RIVENSON A., SIMI B., ZANG E., KELLOFF G., STEELE V., REDDY B.S. Chemoprevention of colon carcinogenesis by sulindac a nonsteroidal anti-inflammatory agent. Cancer Res., 1995, 55: 1464-1472.
47. PIAZZA G.A., ALBERTS D.A., HIXSON L.J. et al. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res., 1997, 57: 2909-2915
48. SHIFF S.J., QIAO L., TSAI L.L., RIGAS B. Sulindac sulfide, an aspirinlike compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J. Clin. Invest., 1995, 96: 491-503.
49. SHENG H., SHAO J., MORROW J.D., BEAUCHAMP D., DU BOIS R.N. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res., 1998, 58: 362-366.
50. PIAZZA G.A., KULCHAK-RAHM A.L., KRUTZSCH M. et al. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res., 1995, 55: 3110-3116.
51. SHIFF S.J., RIGAS B. Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions. Gastroenterology, 1997, 113: 1992-1998.
52. EBERHART C.E., COFFEY R.J., RADHIKA A., GIARDIELLO F.M., FERRENBACH S., DU BOIS R.N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 1994, 107: 1183-1188.
53. OSHIMA M., DINSHUK J.E., KARGMAN S.L. et al. Suppression of intestinal polyposis in APC knockout mice by inhibition of prostaglandin endoperoxide synthase-2 (COX-2). Cell, 1996, 87: 803-809.
54. STEINBACH G., LYNCH P.M., PHILLIPS R.K.S. et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. New Engl. J. Med., 2000, 342: 1946-1952.
55. FARROW D.C., VAUGHAN T.L., HANSTEN P.D. et al. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol. Biom. Prev., 1998, 7: 97-102.
56. FEARON E.R., VOGELSTEIN B. A genetic model for colorectal tumorigenesis. Cell, 1990, 61: 759-767.
57. LYNCH H.T. LYNCH J.F. Cancer prevention, molecular genetics and hereditary cancer syndromes of colon and breast. Eur. J. Cancer Prevention, 1996, 5: 27-32.
58. HILL M.J. Interactions between genetic and environmental factors in colorectal carcinogenesis. Eur. J. Cancer Prevention, 1997, 6: 1-2.